Results 151 to 160 of about 55,687 (218)

Treatment of elderly patients with advanced (M1) gallbladder cancer - Aggressive or conservative?: A retrospective cohort study based on the SEER database. [PDF]

Medicine (Baltimore)
He B, Zhou T, Weng P, Lan H.
europepmc   +1 more source

OLFM4 orchestrates the immunosuppressive microenvironment and drives gallbladder cancer progression. [PDF]

J Cancer Res Clin Oncol
Li W, Liu K, Yang F, He H, Wen W.
europepmc   +1 more source

Correction: The B7 family subgroup reflects tumor cell heterogeneity and patient post-operative prognosis in gallbladder cancer. [PDF]

Biol Direct
Ma C, Hu H, Li Y, Zhong C, Dong Y, Chang Z, Xu S, Zhang Y, Hu H, Lv C, Tian Y.   +10 more
europepmc   +1 more source

Synchronous Intra-ampullary Papillary-Tubular Neoplasm and Gallbladder Cancer. [PDF]

Cureus
Suto K, Kasahara N, Taniguchi M, Meguro Y, Aoki Y, Morishima K, Amori M, Inamura K, Kawata H, Sasanuma H, Yamaguchi H, Sata N.   +11 more
europepmc   +1 more source

Correction: Splicing-mediated control of hnRNPD isoform switching by SRSF2 drives PD-L1-dependent immune evasion in gallbladder cancer. [PDF]

Oncogene
Zhao C, Jiang L, Wang MY, Tang QY, Zhao JW, Yang ZY, Gu J, Song XL, Dong P, Pan LJ, Shu YJ, Gong W.   +11 more
europepmc   +1 more source

Editorial Expression of Concern: Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation. [PDF]

BMC Cancer
Cao X, Yang Y, Zhou W, Wang Y, Wang X, Ge X, Wang F, Zhou F, Deng X, Miao L.   +9 more
europepmc   +1 more source

Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review. [PDF]

Antibodies (Basel)
Caglevic C, Contreras-Torrez MA, Reyes-Cosmelli F, Uribe-Maturana R, Mahave M, Caire N, Villanueva-Olivares L, Cid F, Lladser A, Sapunar J.   +9 more
europepmc   +1 more source

Perioperative chemotherapy for clinical stage IIIB gallbladder cancer: a review of the National Cancer Database. [PDF]

Int J Clin Oncol
Wylie J, Leonard G, White B, Clark C, Levine E, Shen P.   +5 more
europepmc   +1 more source

Molecular convergence in gallbladder cancer: MEK-ERK signalling at the crossroads of oncogenic hubs and pathway cross-talks. [PDF]

Cancer Cell Int
Jaiswar D, Dixit M.
europepmc   +1 more source